Drug intelligence / Profile preview

ginsenoside compound k

Development stage
Phase 1
Modality
Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical, Intravenous
01

Overview

Ginsenoside compound k (人参皂苷C-K) is a rare protopanaxadiol-type saponin metabolite derived from the intestinal microbial transformation of major ginsenosides found in Panax ginseng. It does not naturally occur in raw ginseng but is produced in the human gut after ingestion of other diol-type saponins such as Rb1 and Rd. Ginsenoside compound k exhibits multiple pharmacological activities including anti-tumor, anti-inflammatory, immunomodulatory, hepatoprotective, neuroprotective, and anti-aging effects. Mechanistically, it inhibits inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), modulates TGF-beta/Smad signaling pathways, suppresses memory T cell proliferation (notably CD4+ and CD8+), enhances collagen expression for skin protection against UV damage, and shows potential to enhance efficacy or reduce toxicity of standard chemotherapeutics. It has good water solubility compared to other related compounds like Rg3 or Rh2[2][3][4]. Clinical studies have explored its use for cancer therapy and rheumatoid arthritis[8].

Other names
人参皂苷C-KGinsenoside K
02

Targets

Aβ (Amyloid-beta peptides and aggregates)IKK complexNOS2 (Nitric Oxide Synthase 2)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on ginsenoside compound k.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ginsenoside compound k.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call